Montague County Defective Breast Mesh & Implant Injury Attorneys — Attorney911 (The Manginello Law Firm, PLLC) Provides 27+ Years of Trial Practice and Former Insurance Defense Insights for Texas Plaintiffs Facing BIA-ALCL, BIA-SCC and Reconstruction Device Failures — We Litigate Allergan BIOCELL Textured Implants (Recalled July 2019, MDL No. 2921 Before Judge Brian R. Martinotti, Bellwether October 19, 2026), Mentor MemoryGel, Sientra OPUS, AlloDerm, Strattice ADM and GalaFLEX P4HB Scaffolds — Ralph Manginello and Lupe Peña Handle 21 CFR Parts 803, 807, 814 Violations and Riegel Parallel-Claim Survivability Under Texas Civil Practice & Remedies Code § 16.003 and the Discovery Rule — CD30+/ALK- Pathology, T-Cell Receptor Monoclonality and the Realities of the Northern District of Texas Case Path — $50M+ Recovered for Families and Active $10M Bermudez v. Pi Kappa Phi Litigation Covered by KPRC 2, ABC13 and FOX 26 — Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Montague County: The Definitive Guide for Women, Families, and Survivors For women in Montague County who have undergone breast reconstruction, revision, or cosmetic augmentation, the expectation is always one of healing and restoration. Whether you walked through the doors of a surgical center in North Texas following a courageous battle with breast cancer or sought a mastopexy "internal bra" procedure to regain your confidence, you placed your trust in medical technology. You believed the materials implanted in your body—the surgical meshes, the acellular dermal matrices (ADM), and the bioabsorbable scaffolds—were thoroughly vetted, rigorously tested, and proven safe for use in human breast tissue. The disturbing reality facing many families in Montague County is that the U.S. Food and Drug Administration (FDA) has never formally cleared or approved any surgical mesh product specifically for use in breast surgery. As we move into 2026, a growing wave of litigation and whistleblower testimony has revealed that devices like GalaFLEX, Phasix, AlloDerm, and FlexHD were often brought to market through a regulatory shortcut known as the 510(k) pathway, which bypasses the stringent clinical trials required for most high-risk implants. If you are a resident of Montague County dealing with reconstruction failure, chronic infection, red breast syndrome, or a life-altering diagnosis like BIA-ALCL, we want you to know that you are not alone. At Attorney911 (The Manginello Law Firm, PLLC), we provide the sophisticated, high-stakes representation required to hold multi-billion-dollar medical device manufacturers…